NEW DELHI (Reuters) - India's IPCA Laboratories Ltd said on Thursday that the Global Fund to Fight AIDS, Tuberculosis and Malaria, would no longer buy the company's anti-malarial treatments after a U.S. regulatory warning about quality lapses at its factories.
http://ift.tt/xePdMM
from Reuters: Health News
via
animenewspro
Aucun commentaire:
Enregistrer un commentaire